ISPE’S C&Q COMMUNITY OF PRACTICE (C&Q COP)

2

Primary Purpose of COPs

• Provide a forum for community Members to help each other solve every day work problems and engage in active networking.

• Develop and disseminate best practices, guidelines, procedures, and problem solving for use by community Members.

• Innovate and create breakthrough ideas, knowledge, and practices

• Provide a forum for Members to be able to identify products and services of greatest value to them that can be provided by ISPE

3

Benefits of Joining the C&Q COP

The benefits to joining the Commissioning and Qualification COP are numerous and include:

• Membership is free to all and access to full benefits is available to ISPE members

• Opportunity to share knowledge and experience with other like-minded professionals

• Ability to positively influence the pharmaceutical manufacturing profession

• Offers tools to enhance productivity and keep current with industry trends and developments

• Convenient and efficient global networking opportunities

4

How to Join the C&Q COP

• Go to www.ISPE.org/cops • Click on “Log-in to COPs”• Type your ISPE log-in and password

(Note: if you have never created a log-in or password, you will be automatically prompted)

• Upon logging in, you can access your communities or join a new community by selecting “Join/Unjoin COP” in your menu bar

• Check the box for Commissioning and Qualification and click “Join”

5

Upcoming C&Q COP Activities

• Education Session at ISPE’s Global Annual Meeting, taking place during 25-29th of October 2008 in Boca Raton, FL

• COP Networking Event at ISPE’s Global Annual Meeting on Monday 27th of October 2008

6

2008 C&Q Steering Committee Members

• Chair: Steve Wisniewski, IPS• Co-Chair: Bob Adamson, Foster

Wheeler• Board Liaison: David Petko, Auxilium• Mujtaba Ali, Amylin• Michael Blackton, Imclone Systems• Dr. Joerg Block, Bayer • Nuala Calnan, PM Group• Vincent Cebular, IPS• Peter Werner Christensen, NNE• Kimberly Dahmen, Abbott• Scott Docherty, Proctor & Gamble• David Dolgin, Abbott

• Rose Mary Dollard, Johnson & Johnson

• Daniel Franklin, IPS• Petter Gallon, Astrazeneca• Rick Gunyon, Eli Lilly• Kosal Keo, Genzyme• David Kwilosz, Eli Lilly• Edwin Mahieu, Abbott• Matthew McMenamin, GSK• Gert Moelgaard, NNE• Mark Rezac, Merck• Tulsa Scott, Commissioning Agents• Shannon Yonker, Vice Chairperson

and Secretary/Treasurer at Max Seales Yonker Foundation